-
08/30/2019
PAION signs agreement with Yorkville about the issue of convertible notes of up to EUR 15 million
-
06/28/2019
PAION and the European Investment Bank sign financing agreement for EUR 20 million
-
04/08/2019
PAION announces submission of new drug application for remimazolam by its Licensee Cosmo Pharmaceuticals in the U.S.